Covid test kit
1.Product name : KF94 MASK. 2.Product number : HTM-KF94.3.PRICE :CIF USD1.22/PIECE 4.Product specification 4-1) Korea Food and Drug Administration certified quasi-drug 4-2) A health mask that can protect the respiratory tract from fine dust and yellow dust KF80 and KF94 are classified according to the permission level of the Ministry of Food and Drug Safety in Korea. 4-3) KF94 filters 94% of fine particles (average particle size 0.4�µm) and more than 99% of corona virus. 4-4) Quadruple structure filter It applies a quadruple filter to protect the respiratory system from external particulates such as fine dust and yellow dust.
1.Product name : AGERANIUM BIO PROTECTIVE MEDICAL CLOTH Other name : ICU Surgical Bunny Suits with hood/protective suit/isolation gowns/medical overalls) 2.product number : HETSBS-BIO-04-18 3.product specification Provides the wearer with high quality material Low hazard liquid and particulate level. Ideal for a wide range of general, industrial applications. Features & Benefits Protection Low hazard liquid spray, splash and particle protection Comfort Moisture vapor permeable to help reduce the risk of heat stress Silicone Free Critical in spray painting applications Optimized body fit Improves wearer comfort and safety
1.Product name : BIO PROTECTIVE MEDICAL CLOTH Other name : ICU Surgical Bunny Suits with hood/protective suit/isolation gowns/medical overalls) 2.product number : HDSBS-BIO-04-18 3.product specification 3-1) SF double structure non-woven fabric The breathable film with fine processing and the non-woven fabric are ideally combined to provide moisture permeability and waterproof functions. It is light in weight, soft to the touch and discharges sweat in a vapor state, so it can be worn for a long time 3-2) level : D level Medical protective clothing 4. Manufacture : DELLANURI CO., LTD 5. Sales company : Heachang technology co., ltd 6, Korea Apparel Testing Institute Certification No. :SPEA20-00000170 6-1) Form and model name : DELLANURI SF GUARD-2020 6-2) Grade : D Level 4 Type Protective Clothing 7.The use of the product. 7-1) It is a protective clothing that prevents the penetration of chemicals, viruses and blood. 7-2) When wearing a protective clothing, wear the surrounding situation and equipment, and do not wear it on the bare skin
1.KF 95 Mask : All kinds mask( + Dental Mask) approved by KFDA. 2.Corona Diagnostic Kits.
Anti-splash protective clothing That's NeW!!! Anti-splash Protective Clothing(South KOREA) 10times uses!. Antibacterial Fuction! Excellent Washing Durability! Kill 99.9% of Klebsiella pneumoniae ATCC 4352 KOREA CERTIFICATION (KC) Charicteristics - Fabric - 10 time uses - Anti-bacterial fuction - Splash penetration resistance - Easy to wear - Washing Durabillity - Kil 99.9% of Klebsiella pneumoniae ATCC 4352 - Textile product safety certification for children(KOREA CERTIFICATION_KC) - Maintain antibacterial effect until washing 10 times - Water-repellet fuction to bounce off the splash. - Micro porous type coating layer to prevent splash - Excellent splash penetration protection by triple protection layer Size & Type 1) Kid : S / M / L / XL 2) Adult : Men/Women 3) Coverall MOQ 300ea Payment T/T Thank you.
Its use has proven to work efficiently for installation and maintenance of hvac industry both domestic and international market. Dehydrated and hard drawn straight tube is end-capped for extra cleanness and product quality.
MEDIKORS Inc. develope InAlyzer the worlds first digital diagnostic X-ray imaging system uses DXA(Dual X-ray Absorptiometry). InAlyzer can analyze Bone Mineral Density and Body Composition(BMC, FAT, LEAN) of alive laboratory animal in units of 0.001g with simple anesthesia without killing them. And it is possible to track and observe the follow-up for each entity of alive lab animals that can save the time, labor, and cost practically. Moreover, InAlyzer have researcher be safe from the radiation by blocking out the outside exposure of the radiation with internal protection structure. Additionally, InAlyzer approved the effectiveness, accuracy, and successful qualification in the preclinical phase.
Adhesive Bandages with PVC and Non-woven cushion pad with pe net. 20 PCS/Box, 12 Boxes/DP Box, 20 DP Boxes/CTN 270 X 405 X 545
The GENEDIA W COVID-19 Ag is an in vitro diagnostic single-use test and qualitative immunoassay to detect SARS-CoV-2 antigen in nasopharyngeal swab and sputum specimen from human. This assay is designed for professional personnel in laboratory and at point-of-care as an aid in screening patients suspected of being infected and asymptomatic patients. Allow wider testing with fast test time (10 minutes) Clinically proven data of asymptomatic patients available Separately packed extraction solution to minimize the possibility of contamination No additional instruments required Package Unit : 20 Tests/Kit Expiration Date : 24 Months (while sealed in the original aluminum foil pouch) GCMS manufactures COVID-19 antigen test kit, the GENEDIA W COVID-19 Ag which is listed on the EU common list, also with GMP and ISO certifications. GENEDIA W COVID-19 Ag is unaffected based on the in-silicon analysis of the mutations in the nucleocapsid (N gene) of Omicron viruses. Letter of statement is available upon your request. To get over COVID-19 pandemic, especially the recent Omicron breakout, currently we are doing big promotions for three kinds of COVID-19 Ag kit. All are in stock and available right away. 1. Nasopharyngeal 2. Nasal 3. Saliva The price is negotiable according to the amount of your order and shipping term. No MOQ is required but we prefer 1 pallet with 9,600 tests. (20 tests/kit, 30 kits/carton, 16 cartons/pallet)
Fatness measuring machine using in all hospitals. Stadiometer using at academy, home and fitness
EPS PELLET - A LIST, A LIGHT YELLOW COLOR, 20-60 TONS MONTHLY
INTENDED USE A rapid animal diagnostic test kit for simple antigen detection that can check the presence of coronavirus antigens in dog feces and diagnose the sample with a simple operation within 10 minutes. Symptom of a disease The virus that enters the dogs mouth reaches the small intestines through the stomach, multiplies in the mucous membrane, secretes toxic substances, and destroys the intestinal mucous membrane. The main symptoms of coronavirus are enteritis or diarrhea. However, it is not fatal and shows symptoms such as vomiting and dehydration.
INTENDED USE A rapid animal diagnostic test kit for simple antigen detection that can check the presence of parvovirus antigens in dog feces and diagnose the sample with a simple operation within 10 minutes. Symptom of a disease It is infected by contact or oral cavity through the feces of an infected dog. Symptoms are diarrhea and are highly contagious diseases. The parvovirus first develops within 48 to 72 hours. In dogs infected for more than eight weeks, it usually causes vomiting, stinky gray diarrhea or bloody excrement, rapid weakness, and loss of appetit
MastoCheck is a blood test that can easily screen for breast cancer at an early stage. Breast cancer is diagnosed early by substituting the quantitative values of three types of protein biomarkers in the blood, which are closely related to breast cancer, into a unique, patented algorithm. An innovative and convenient test method that detects early breast cancer with an accuracy of 92% (based on the patent) by using only a very small amount of blood. Bertis has developed multiple markers that can detect early breast cancer with an accuracy of 92% through identification of multiple proteins that are expressed sensitively in early-stage breast cancer and combination of certain proteins that demonstrated high accuracy and reproducibility among these combinations. DEVELOPMENT PROCESS: - MASTOCHECK was developed by a team led by Professor Dong-Young Noh, a world-renowned authority on breast cancer, of Seoul National University. - After analyzing approximately 600,000 proteins and selecting 3 markers exhibiting optimal accuracy, the highest accuracy was obtained by adding Bertis�¢?? own algorithm that enhances accuracy. - After several years of repeated validation work, a medical device product license was obtained from the MFDS in January 2019. To date (as of September 2023), MASTOCHECK has been introduced to about 400 hospitals and screening institutions nationwide, with priority given to large screening institutions.
OVCHECK have secured a marker that can diagnose ovarian cancer with an accuracy of 95% or higher (sensitivity of 100% and specificity of 91%), and the project is currently in the clinical validation stage. OVCHECK DEVELOPMENT PROCESS Bertis is currently developing a highly accurate early ovarian cancer diagnosis technology with Seoul National University Hospital Gangnam Center. The tumor markers CA125 and HE4, the conventional biomarker for ovarian cancer testing, have limitations in the early screening of ovarian cancer due to their low sensitivity and specificity. Bertis is developing a technology that enables a more accurate diagnosis of ovarian cancer and is currently in the clinical verification stage by securing markers to diagnose ovarian cancer with more than 95% accuracy (100% sensitivity and 91% specificity).
PANCCHECK is a blood test solution that enables early diagnosis of pancreatic cancer with 94% accuracy is under development. PANCCHECK DEVELOPMENT PROCESS: While effective early diagnostic methods for pancreatic cancer are currently lacking, BERTIS is developing a technology that enables early diagnosis of pancreatic cancer with a small blood sample. Through research, we have identified 10 protein biomarkers as a diagnostic marker panel for pancreatic cancer. Following algorithm development and validation, we have uncovered a combination of markers that demonstrates a high accuracy of 98% and is applicable in clinical settings.
Global proteomics (Cell, Tissue, blood proteome) Label-free analysis based on data-independent acquisition (DIA). Our industry-leading protein analysis of non-depleted plasma can result in 1,300 protein identifications in one-hour per single sample. Our isotope-labeling enables a sample-to-sample comparison analysis in protein quanti�cation. Bertis labeling quantification and advanced fractionation technology enable industry-leading protein quantification analysis in cell or tissue samples. Our phospho/glyco proteomics ensures high-quality post-translational modification (PTM) analysis of proteins, providing an optimized solution for biomarker discovery and mechanism of action analysis. Our bioinformatics analysis provides your research needs from basic analysis of protein composition and quantiy cation to in-depth systems biology analysis. We provide analysis services that meet our customer's needs through continuous communication and interaction.
Companion Diagnostics (CDx) provide a companion diagnostic solution through pathway analysis based on RNA and protein quantification information respective to subtypes from each diseases. For precision medicines developed based on multi-omics analysis, biomarkers can be used to identify target patients in advance. Global pharmaceutical companies are active in the use of companion diagnostics as a key strategic tool in clinical development programs. PASS provides solutions for the entire process from discovery of drug candidates to non-clinical to clinical trials through pan-omics technology. Bertis has array of innovative and reliable technology to increase the safety and efficacy of an investigational drug across the clinical research landscape, including solutions for the discovery of biomarkers for companion diagnostics and the determination of clinical targets through functional analysis.
Protein Characterization (Physicochemical property of proteins) structure analysis using mass spectrometry provides results that meet the requirements of the FDA, the MFDS and other regulatory authorities regarding novel therapies or biosimilars. Based on basic amino acid analysis (full sequencing), we perform post-translational modification (PTM) analysis, which is important for protein potency and stability. In this regard, we can perform test methods based on design of experiment (DOE) statistical methodology and deliver documents to be submitted to regulatory authorities. Protein identification and quantification : Structural analysis of all types of protein therapeutics, including monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), and enzymes - Full Length-Amino acids sequencing Peptide identification of each peak through peptide mapping (MS spectrum confirmation, MS/MS spectral analysis with 100% AA matches) - Improved N- and C-terminal sequencing of proteins Post-translational modification (PTM) : More reliable results based on design of experiment (DOE) statistical methodology to perform the experiments systematically and analyze data efficiently - Disulfide bond analysis ID Total possible lankage analysis - Deamidation identification and quantification - Phosphorylation identification and quantification , phospho-proteomic analysis - Other functional modifications Glycomics : Single protein analysis and research of protein complexes with glycosylation closely related to biological function and toxicity as well as structural stability of proteins - Glycosylation site determination - Glycan profiling - Site-specific glycan identification and quantification - Glycomics research with glycan enrichment
